Predicate Research Report · generated 2026-08-22 · Print / save as PDF · Save to account
Olympus Corporation — Predicate Candidate Screening
5 FDA 510(k) clearances under this manufacturer; the 50 most recent screened below.
27 daysmedian FDA review time
59 days90th percentile
5clearances measured
| K-number | Device | Applicant | Decided | Review days | Recalls (K-match) |
|---|---|---|---|---|---|
| K072643 | CRYSTALEYE SPECTROPHOTOMETER/CRYSTALEYE BASIC SET, MODEL CE1 | Olympus Corporation | 2007-11-16 | 59 | 0 |
| K043128 | OLYMPUS ENDOARM | Olympus Corporation | 2004-12-21 | 39 | 0 |
| K042140 | OLYMPUS BF TYPE UC160-OL8 | Olympus Corporation | 2004-08-18 | 9 | 0 |
| K041494 | OLYMPUS INTEGRATED ENDOSURGERY SYSTEM ENDOALPHA (CONTROL UNI | Olympus Corporation | 2004-07-01 | 27 | 0 |
| K040940 | BRONCHOVIDEOSCOPE OLYMPUS XBF-D160HM | Olympus Corporation | 2004-04-19 | 7 | 1 |
Methodology
Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.
Prepared with Atlas
Predicate research, review-time statistics and recall monitoring for 510(k) teams — atlasbyauro.com/fda